Simultaneous and sensitive LC–MS/MS determination of tetrahydrocannabinol and metabolites in human plasma
- 873 Downloads
Cannabis is not only a widely used illicit drug but also a substance which can be used in pharmacological therapy because of its analgesic, antiemetic, and antispasmodic properties. A very rapid and sensitive method for determination of ∆9-tetrahydrocannabinol (THC), the principal active component of cannabis, and two of its phase I metabolites in plasma has been developed and validated. After solid-phase extraction of plasma (0.2 mL), the clean extracts were analyzed by tandem mass spectrometry after a 5-min liquid chromatographic separation. The linear calibration ranges were from 0.05 to 30 ng mL−1 for THC and 11-nor-∆9-carboxy-tetrahydrocannabinol (THC-COOH) and from 0.2 to 30 ng mL−1 for ∆9-(11-OH)-tetrahydrocannabinol (11-OH-THC). Imprecision and inaccuracy were always below 7 and 12 % (expressed as relative standard deviation and relative error), respectively. The method has been successfully applied to determination of the three analytes in plasma obtained from healthy volunteers after oral administration of 20 mg dronabinol.
KeywordsTHC Metabolites LC–MS/MS Cannabinoids
This study was supported in part by the “Landesoffensive zur Entwicklung wissenschaftlich-ökonomischer Exzellenz: LOEWE. Schwerpunkt: Anwendungsorientierte Arzneimittelforschung” (GG, JL), the “Deutsche Forschungsgemeinschaft, DFG Lo 612/10-1 (JL)”, and the European Graduate School GRK757 (GG, JL).
- 1.EMCDDA (2011) The State of the Drugs Problem in Europe, Annual Report 2011. European Monitoring Centre for Drugs and Drug AddictionGoogle Scholar
- 4.Husseini L, Leussink VI, Warnke C, Hartung HP, Kieseier BC (2011) Cannabinoids for symptomatic therapy of multiple sclerosis. Nervenarzt. doi: 10.1007/s00115-011-3401-9
- 13.Elian AA, Hackett J (2009) Solid-phase extraction and analysis of THC and carboxy-THC from whole blood using a novel fluorinated solid-phase extraction sorbent and fast liquid chromatography–tandem mass spectrometry. J Anal Toxicol 33:461–468Google Scholar
- 16.de Jager AD, Bailey NL (2011) Online extraction LC-MS/MS method for the simultaneous quantitative confirmation of urine drugs of abuse and metabolites: amphetamines, opiates, cocaine, cannabis, benzodiazepines and methadone. J Chromatogr B Anal Technol Biomed Life Sci 879:2642–2652CrossRefGoogle Scholar
- 24.Chebbah C, Pozo OJ, Deventer K, Van Eenoo P, Delbeke FT (2010) Direct quantification of 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid in urine by liquid chromatography/tandem mass spectrometry in relation to doping control analysis. Rapid Commun Mass Spectrom 24:1133–1141CrossRefGoogle Scholar
- 26.Molnar A, Lewis J, Doble P, Hansen G, Prolov T, Fu S (2011) A rapid and sensitive method for the identification of delta-9-tetrahydrocannabinol in oral fluid by liquid chromatography–tandem mass spectrometry. Forensic Sci Int. doi: 10.1016/j.forsciint.2011.01.045:
- 27.Walter C, Oertel BG, Felden L, Nöth U, Deichmann R, Lötsch J (2011) The effects of delta-9-tetrahydrocannabinol on nasal chemosensitivity: a pharmacological fMRI study in healthy volunteers. Naunyn Schmiedebergs Arch Pharmacol 383(Suppl 1):75Google Scholar
- 28.Guidance for Industry: Bioanalytical Method Validation (2001) US Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, Rockville, USA www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm070107.pdf. Accessed 21 Jun 2012
- 30.Validation of Analytical Procedures: Text and Methodology Q2(R1) (2005) ICH. International Conference on Harmonisation of Technical Requirements, ICH Harmonised Tripartite Guideline, Geneva, Switzerland. http://private.ich.org/LOB/media/MEDIA417.pdf. Accessed 21 Jun 2012
- 32.Wall ME, Perez-Reyes M (1981) The metabolism of delta 9-tetrahydrocannabinol and related cannabinoids in man. J Clin Pharmacol 21:178S–189SGoogle Scholar
- 34.Dubois N, Paccou AP, De Backer BG, Charlier CJ (2012) Validation of the quantitative determination of tetrahydrocannabinol and its two major metabolites in plasma by ultra-high-performance liquid chromatography–tandem mass spectrometry according to the total error approach. J Anal Toxicol 36:25–29CrossRefGoogle Scholar